Biohaven Ltd (NYSE:BHVN) shares, rose in value on Thursday, December 12, with the stock price down by -6.15% to the previous day’s close as strong demand from buyers drove the stock to $40.16.
Actively observing the price movement in the last trading, the stock closed the session at $42.79, falling within a range of $40.0301 and $42.555. Referring to stock’s 52-week performance, its high was $62.21, and the low was $26.80. On the whole, BHVN has fluctuated by -20.25% over the past month.
With the market capitalization of Biohaven Ltd currently standing at about $4.06 billion, investors are eagerly awaiting this quarter’s results, scheduled for in January.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 9.09M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BHVN’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of BHVN currently trading nearly -10.64% and -17.86% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 33.49, while the 7-day volatility ratio is showing 5.64% which for the 30-day chart, stands at 6.41%. Furthermore, Biohaven Ltd (BHVN)’s beta value is 3.83, and its average true range (ATR) is 2.60.
A comparison of Biohaven Ltd (BHVN) with its peers suggests the former has fared considerably weaker in the market. BHVN showed an intraday change of -6.15% in last session, and over the past year, it grew by 12.34%%.
Data on historical trading for Biohaven Ltd (NYSE:BHVN) indicates that the trading volumes over the past 10 days have averaged 0.63 and over the past 3 months, they’ve averaged 1.01 million. According to company’s latest data on outstanding shares, there are 94.90 million shares outstanding.
Nearly 12.36% of Biohaven Ltd’s shares belong to company insiders and institutional investors own 86.11% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.84 million shares as on 2024-11-29, resulting in a short ratio of 9.66. According to the data, the short interest in Biohaven Ltd (BHVN) stood at 871.00 of shares outstanding as of 2024-11-29; the number of short shares registered in 2024-10-31 reached 9.15 million. The stock has fallen by -6.17% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BHVN stock heading into the next quarter.
